FindTrial
Sign In

Development of a standardized protocol of neurological manifestations in patients with SARS-CoV-2

Development of a standardized protocol of neurological manifestations in patients with SARS-CoV-2

Status
Recruiting
Phases
Unknown
Study type
Interventional
Source
REBEC
Registry ID
RBR-96wctgg
Enrollment
Unknown
Registered
2022-01-31
Start date
2021-01-05
Completion date
Unknown
Last updated
2025-10-27

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

SARS-CoV-2 infection

Interventions

Participants will be instructed to refrain from vigorous activities, consumption of beverages containing caffeine or alcohol, and tobacco use for 24 hours before each training session. Individuals wil
D015444
D009483

Sponsors

Universidade Federal do Triângulo Mineiro
Lead Sponsor
Universidade Federal do Triângulo Mineiro
Collaborator

Eligibility

Age
18 Years to No maximum

Inclusion criteria

Inclusion criteria: Individuals over 18 years of age in the acute and subacute phase of COVID-19; functional status between 0 to 2; schooling over 9 years (complete high school); who can independently respond to the test

Exclusion criteria

Exclusion criteria: Individuals who do not adhere to the intervention protocol with one or more absences; who have some type of motor or cognitive impairment during the study period; who present clinical instability during the intervention

Design outcomes

Primary

MeasureTime frame
It is expected to find an increase in cognitive performance, verified through the Sensory CogScore4 Mobile method, from the observation of a variation of at least 15% in pre- and post-intervention measurements—

Secondary

MeasureTime frame
Secondary outcomes are not expected—

Countries

Brazil

Contacts

Public ContactGustavo Luvizutto
gluvizutto@gmail.com+55(34)999151611

Outcome results

None listed

Source: REBEC (via WHO ICTRP)